April 6, 2007 - Hospira Inc. introduced a new wireless platform for its medication infusion devices that incorporates leading-edge authentication standards and encryption protocols to assist hospitals in securely transferring data and complying with patient confidentiality regulations. The new technology also provides the first three- in-one wireless multi-band module for an infusion system, enabling hospitals to select any of three frequency modes for communication.

The platform's expanded security options help ensure only designated, approved hospital staff access clinical data transmitted between the devices and hospital information technology systems as part of the intravenous (I.V.) medication administration process. This can help healthcare providers more readily comply with patient confidentiality regulations, such as the Health Insurance Portability and Accountability Act, or HIPAA, in securing patient data against inadvertent release.

Most wireless products, such as mobile phones, pagers and other medical devices, communicate via the 802.11 "b" or "g" modes on the 2.4 GHz band. With Hospira's new platform, hospitals can choose to operate the company's infusion devices in the "b" or "g" modes, as well as the less frequently used "a" (5 GHz band) wireless mode, to help ensure clear, consistent data transmission.

Hospira is currently offering this new capability with the Plum A (R) single-channel infusion device and will be adding it to its Plum A (R)3 triple-channel device, LifeCare PCA(R) patient-controlled analgesia system and Symbiq(TM) infusion system later this year. The devices work in conjunction with the Hospira MedNet(R) system, a scaleable and upgradeable patient safety platform.


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Subscribe Now